Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mira Namba

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Health Science Reports|January 10, 2024
Challenges and opportunities of LGBTQ health nudgingYudai Kaneda, Mira Namba
JMA Journal|November 9, 2023
Potential Risk of Overlooking Biased Reporting of Vaccination against Novel Coronavirus Disease 2019: Lessons from Japan's Experience with the Human Papillomavirus VaccineYudai Kaneda, Mira Namba
QJM : Monthly Journal of the Association of Physicians|December 20, 2024
Obstetrics under pressure from work style reform: towards pregnant mothers-centered care in JapanMira Namba, Yudai Kaneda
Health Science Reports|July 13, 2023
A call for bridging gender gap in HPV vaccination policies in JapanYudai Kaneda, Mira Namba, Tshewang Gyeltshen
Industrial Health|May 25, 2025
Association of severity of premenstrual disorders with absenteeism and presenteeism among Japanese working women: a cross-sectional studyMiho Iida, Mira Namba, Kyoko Nomura
JMA Journal|February 5, 2024
Navigating Japan's COVID-19 Vaccination Challenges: A Shift in Legal Classification and the Opt-out SystemYudai Kaneda, Mira Namba, Masaki Takebayashi
Therapeutic Advances in Vaccines and Immunotherapy|December 13, 2023
Stagnation or safety? Reassessment of the human papillomavirus vaccination dosing regimen in JapanMira Namba, Yudai Kaneda, Miho Iida
Cureus|June 13, 2024
Bridging the Gap in United Nations Environment Programme's Report: The Potential of Nudges to Reduce Plastic Pollution and Health RisksMira Namba, Yudai Kaneda, Tetsuya Tanimoto, et al.
Cureus|October 4, 2023
Artificial Intelligence in Childcare: Assessing the Performance and Acceptance of ChatGPT ResponsesYudai Kaneda, Mira Namba, Uiri Kaneda, et al.
Nature|February 6, 2024
Clinical trials: Japan's opt-out policy raises risks of adverse drug responsesMira Namba, Yudai Kaneda, Akihiko Ozaki, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Health Science Reports|January 10, 2024
Challenges and opportunities of LGBTQ health nudgingYudai Kaneda, Mira Namba
JMA Journal|November 9, 2023
Potential Risk of Overlooking Biased Reporting of Vaccination against Novel Coronavirus Disease 2019: Lessons from Japan's Experience with the Human Papillomavirus VaccineYudai Kaneda, Mira Namba
QJM : Monthly Journal of the Association of Physicians|December 20, 2024
Obstetrics under pressure from work style reform: towards pregnant mothers-centered care in JapanMira Namba, Yudai Kaneda
Health Science Reports|July 13, 2023
A call for bridging gender gap in HPV vaccination policies in JapanYudai Kaneda, Mira Namba, Tshewang Gyeltshen
Industrial Health|May 25, 2025
Association of severity of premenstrual disorders with absenteeism and presenteeism among Japanese working women: a cross-sectional studyMiho Iida, Mira Namba, Kyoko Nomura
JMA Journal|February 5, 2024
Navigating Japan's COVID-19 Vaccination Challenges: A Shift in Legal Classification and the Opt-out SystemYudai Kaneda, Mira Namba, Masaki Takebayashi
Therapeutic Advances in Vaccines and Immunotherapy|December 13, 2023
Stagnation or safety? Reassessment of the human papillomavirus vaccination dosing regimen in JapanMira Namba, Yudai Kaneda, Miho Iida
Cureus|June 13, 2024
Bridging the Gap in United Nations Environment Programme's Report: The Potential of Nudges to Reduce Plastic Pollution and Health RisksMira Namba, Yudai Kaneda, Tetsuya Tanimoto, et al.
Cureus|October 4, 2023
Artificial Intelligence in Childcare: Assessing the Performance and Acceptance of ChatGPT ResponsesYudai Kaneda, Mira Namba, Uiri Kaneda, et al.
Nature|February 6, 2024
Clinical trials: Japan's opt-out policy raises risks of adverse drug responsesMira Namba, Yudai Kaneda, Akihiko Ozaki, et al.
Pageof 3